Prudent Man Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,924
Closed -$211K 181
2023
Q4
$211K Sell
1,924
-230
-11% -$23.8K 0.08% 169
2023
Q3
$217K Sell
2,154
-68
-3% -$7.81K 0.09% 162
2023
Q2
$302K Hold
2,222
0.11% 142
2023
Q1
$231K Buy
+2,222
New +$215K 0.09% 162
2022
Q2
Sell
-2,020
Closed -$300K 169
2022
Q1
$300K Sell
2,020
-94
-4% -$13.1K 0.12% 128
2021
Q4
$300K Buy
+2,114
New +$299K 0.11% 133

Other funds holding CNMD

Prudent Man Advisors's CNMD Position: Q1 2024 in Review

Prudent Man Advisors sold out of CONMED (CNMD) in Q1 2024, closing a stake of 1,924 shares — an estimated $211K sold.

Prudent Man Advisors first reported a position in CNMD in Q4 2021 and held it in 6 quarters. The position peaked at $302K in Q2 2023. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Prudent Man Advisors reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Prudent Man Advisors sold 1,924 CONMED shares in Q1 2024, an estimated $211K.
  • Prudent Man Advisors first reported a position in CONMED in Q4 2021 and held it in 6 quarters.
  • Prudent Man Advisors's CONMED position peaked at $302K in Q2 2023.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Prudent Man Advisors's 13F filing for Q1 2024, filed 14 May 2024.